Sign in to view content

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

David M. Brown, MD

Video
Published 2021

Related

Cost of Initial Aflibercept, Laser, or Observation in Eyes With Diabetic Macular Edema and Good Vision Based on Management Approaches in Protocol V
Jennifer K. Sun, MD
Annual Meeting Talks
2020
Impact of Posterior Vitreous Detachment at Baseline on Treatment Outcomes For Diabetic Macular Edema in the VISTA and VIVID Trials
Ferhina S Ali, MD, MPH
On Demand Cases, Courses, and Papers
2017
Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results
Sam E. Mansour, MD, MSc,FACS, FRCS(C)
Annual Meeting Talks
2018

Category: Pharmacology

See more